Evoke (EVOK) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Nov, 2025Executive summary
Achieved fourth consecutive quarter of revenue growth, with H1 2025 revenue up 3% year-over-year to £887.8m, driven by strong international performance and retail recovery.
Adjusted EBITDA rose 44% year-over-year to £166m, reflecting operational efficiency, cost savings, and improved marketing returns.
Significant deleveraging, with leverage reduced to 5.0x from 6.7x a year ago, and a target below 3.5x by 2027.
International segment led growth with revenue up 13% and Adjusted EBITDA more than doubling; UK & I Online revenue declined 1% but profitability improved, and Retail returned to growth in Q2 after new gaming machine rollout.
Enhanced gross margin, improved marketing efficiency, and a more efficient operating model contributed to profitability.
Financial highlights
H1 2025 revenue grew 3% year-over-year to £887.8m; constant currency revenue up 4%.
Adjusted EBITDA up 44% to £166m; margin improved to 18.7% from 13.4% in H1 2024.
International segment revenue up 13% to £299.4m; Adjusted EBITDA up 111% to £85.6m.
UK & I Online revenue down 1% to £336.2m, but Adjusted EBITDA up 37% to £60.0m.
Retail revenue down 2% to £252.2m; Adjusted EBITDA down 22% to £29.6m, but Q2 saw gaming growth after rollout of 5,000 new machines.
Outlook and guidance
FY 2025 guidance reiterated: 5-9% revenue growth and at least 20% Adjusted EBITDA margin.
Medium-term targets: 5-9% annual revenue growth, ~100bps EBITDA margin expansion per year, and leverage below 3.5x by end of 2027.
H2 2025 expected to see further profitability gains, supported by new product launches and operational initiatives.
Capex for FY25 expected at £100-110m, with interest costs of £175-180m.
Latest events from Evoke
- H1 lagged plans, but cost savings and new products set up 5%-9% H2 growth and margin recovery.EVOK
Trading Update3 Feb 2026 - Revenue down, losses widen, but transformation and H2 margin recovery on track.EVOK
H1 20241 Feb 2026 - FY25 revenue up 2%, EBITDA up 14-15%, with a strategic review amid UK tax hikes.EVOK
Q4 2025 TU27 Jan 2026 - Growth resumed in 2024 with rising margins, strong core markets, and a clear deleveraging plan.EVOK
H2 202426 Dec 2025 - Business transformation, renewed growth, and enhanced governance were key AGM themes.EVOK
AGM 202527 Nov 2025 - Revenue up 5% in Q3 2025, all divisions grew, and FY25 EBITDA margin guidance reaffirmed.EVOK
Q3 2025 TU28 Oct 2025 - Q2 revenue up 5% and Adjusted EBITDA up 43% year-over-year, with FY25 guidance reaffirmed.EVOK
H1 2025 TU22 Jul 2025 - Double-digit online growth and strong international gains drive evoke's Q3 revenue rebound.EVOK
Trading Update13 Jun 2025 - Q1 revenue up 1% to £437m, with strong international growth and higher EBITDA.EVOK
Trading Update6 Jun 2025